Industry News

Colorado State University broke ground in October of 2024 on ATLAS, the Advanced Technology Lasers for Applications and Science facility in Fort Collins. Created in collaboration with the U.S. Department of Energy’s Fusion Energy Sciences program, the development is made possible by a $150 million public-private partnership with Marvel Fusion. A trio of ultra-high-power lasers that can be used separately or in combination will drive innovative discoveries in clean energy, medicine, and fundamental research.

MilliporeSigma, a subsidiary of Merck KGaA, opened a $317.2 million facility in Rockville in October of 2024. Located in the Alexandria Center at Traville Gateway, the 260,000-sf building provides advanced laboratories for biosafety testing, analytical development, viral clearance, and cell bank manufacturing. The project represents the company's largest investment to date in contract testing operations.

Aviva Investors is constructing the 60,000-sf Sidney Sussex Building in Cambridge in the United Kingdom. Located at the Chesterford Research Park, the 60,000-sf life sciences facility will provide 10 individual laboratory environments in an inspiring natural setting. Each fully fitted suite will include open office areas and wet lab space equipped with benches, sinks, and fume hoods, supported by a dedicated plant room located on the same level. A floor of shared conference venues will promote collaboration and exchange.

AstraZeneca officially opened The Hub on the Cambridge Biomedical Campus in October of 2024. Designed by Herzog & de Meuron, this dynamic amenities center offers inviting settings for collaboration, engagement, and relaxation that are available to both corporate employees and the local community. The facility's 39,460-sf internal floor area accommodates a fitness center, treatment rooms, and areas for health screening and occupational health services. Other features include a nursery and preschool, a café, a bar, a shop, and an inviting garden.

King Street Properties has announced the substantial completion of the South Building at the Landing, a purpose-built complex for biomedical innovation. Designed by Perkins&Will, the seven-story, 300,000-sf facility offers 46,500-sf floor plates and advanced MEP systems to support a 60/40 lab-to-office ratio. Robust research programs can be accommodated by 15-foot deck-to-deck heights, with expansive 20-foot heights available on the ground floor.